Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (341-350 of 415) with videos related to

Pageof 42
Sort By:
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Cancers|August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
The Clinical Journal of Pain|February 6, 2015
Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settingsSebastiano Mercadante, Marzia Lazzari, Carlo Reale, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2021
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to ImmunotherapyStefano Scalera, Marco Mazzotta, Giacomo Corleone, et al.
In Vivo (Athens, Greece)|October 26, 2021
Prediction of Recurrence by Machine Learning in Salivary Gland Cancer Patients After Adjuvant (Chemo)RadiotherapyFrancesca De Felice, Valentino Valentini, Marco De Vincentiis, et al.
Journal of Clinical Medicine|April 30, 2021
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future PerspectivesEriseld Krasniqi, Maddalena Barba, Aldo Venuti, et al.
Cancers|April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus ReviewMattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
Oncotarget|March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinomaDaniele Santini, Matteo Santoni, Alessandro Conti, et al.
Journal of Translational Medicine|July 13, 2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy eraAndrea Botticelli, Giulia Pomati, Alessio Cirillo, et al.
Pageof 42

Showing results (341-350 of 415) with videos related to

Sort By:
Pageof 42
Cancer Immunology, Immunotherapy : CII|March 3, 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approachAndrea Botticelli, Alessio Cirillo, Giulia Pomati, et al.
Cancers|August 27, 2021
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, et al.
The Clinical Journal of Pain|February 6, 2015
Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settingsSebastiano Mercadante, Marzia Lazzari, Carlo Reale, et al.
Cancers|September 3, 2020
Evaluation of Prognostic Factors for Survival in Transverse Colon CancerMichela Roberto, Giulia Arrivi, Francesca Lo Bianco, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2021
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to ImmunotherapyStefano Scalera, Marco Mazzotta, Giacomo Corleone, et al.
In Vivo (Athens, Greece)|October 26, 2021
Prediction of Recurrence by Machine Learning in Salivary Gland Cancer Patients After Adjuvant (Chemo)RadiotherapyFrancesca De Felice, Valentino Valentini, Marco De Vincentiis, et al.
Journal of Clinical Medicine|April 30, 2021
Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future PerspectivesEriseld Krasniqi, Maddalena Barba, Aldo Venuti, et al.
Cancers|April 23, 2022
Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus ReviewMattia Garutti, Gaia Griguolo, Andrea Botticelli, et al.
Oncotarget|March 31, 2016
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinomaDaniele Santini, Matteo Santoni, Alessandro Conti, et al.
Journal of Translational Medicine|July 13, 2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy eraAndrea Botticelli, Giulia Pomati, Alessio Cirillo, et al.
Pageof 42